In this guideline, FIB-4 was compared to other scores like AST to Platelet Ratio Index (APRI), NAFLD fibrosis score (NFS), AST/ALT ratio and BARD [19]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.